Risk behaviours and benign prostatic hyperplasia

被引:54
|
作者
Kang, D
Andriole, GL
Van de Vooren, RC
Crawford, D
Chia, D
Urban, DA
Reding, D
Huang, WY
Hayes, RB
机构
[1] NCI, Div Canc Epidemiol & Genet, DHHS, Bethesda, MD 20892 USA
[2] Seoul Natl Univ, Coll Med, Dept Prevent Med, Seoul, South Korea
[3] Washington Univ, St Louis, MO USA
[4] Univ Utrecht, Utrecht, Netherlands
[5] Univ Colorado, Hlth Sci Ctr, Denver, CO USA
[6] Univ Calif Los Angeles, Los Angeles, CA USA
[7] Univ Alabama, Birmingham, AL USA
[8] Marshfield Med Res & Educ Fdn, Marshfield, WI USA
关键词
smoking; alcohol; BPH; PLCO; risk;
D O I
10.1111/j.1464-410X.2004.04839.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE To identify risk factors for benign prostatic hyperplasia (BPH). SUBJECTS AND METHODS Medical history data, including reported urological conditions and treatments, and risk factor data were collected from 34 694 participants in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial, a randomized controlled trial designed to evaluate methods for the early detection of cancer. RESULTS Asian men had the lowest risks (odds ratio, 95% confidence interval) for nocturia (0.7, 0.5-0.9), physician-diagnosed BPH (0.3, 0.2-0.5) and transurethral prostatectomy (TURP, 0.2, 0.1-0.6), while risks for Whites and Blacks were similar for most measures of BPH. Greater alcohol intake was associated with decreased nocturia (P trend = 0.002), BPH (P trend < 0.001) and TURP (P trend < 0.001). Current tobacco use was associated with decreased nocturia (0.8, 0.7-0.9), BPH (0.7, 0.6-0.8) and TURP (0.6, 0.4-0.8) but dose-response patterns were weak. CONCLUSION Asian-Americans have the lowest risk of clinical BPH. Alcohol and possibly cigarettes are related to a lower risk for BPH.
引用
收藏
页码:1241 / 1245
页数:5
相关论文
共 50 条
  • [1] Risk factors for benign prostatic hyperplasia
    Jacobsen S.J.
    [J]. Current Urology Reports, 2007, 8 (4) : 281 - 288
  • [2] Food groups and risk of benign prostatic hyperplasia
    Bravi, F
    Bosetti, C
    Dal Maso, L
    Talamini, R
    Montella, M
    Negri, E
    Ramazzotti, V
    Franceschi, S
    La Vecchia, C
    [J]. UROLOGY, 2006, 67 (01) : 73 - 79
  • [3] Metformin use and risk of benign prostatic hyperplasia
    Norgaard, Mette
    Darvalics, Bianka
    Thomsen, Reimar W.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 417 - 417
  • [4] Atherosclerosis as a risk factor for benign prostatic hyperplasia
    Berger, Andreas P.
    Bartsch, Georg
    Deibl, Martina
    Alber, Hannes
    Pachinger, Otmar
    Fritsche, Gernot
    Rantner, Barbara
    Fraedrich, Gustav
    Pallwein, Leo
    Aigner, Fritz
    Horninger, Wolfgang
    Frauscher, Ferdinand
    [J]. BJU INTERNATIONAL, 2006, 98 (05) : 1038 - 1042
  • [5] Review of Exercise and the Risk of Benign Prostatic Hyperplasia
    Sea, Jason
    Poon, Kenneth S.
    McVary, Kevin T.
    [J]. PHYSICIAN AND SPORTSMEDICINE, 2009, 37 (04): : 82 - 90
  • [6] Benign prostatic hyperplasia
    Clarke, HS
    [J]. AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1997, 314 (04): : 239 - 244
  • [7] BENIGN PROSTATIC HYPERPLASIA
    HULBERT, JC
    [J]. SEMINARS IN INTERVENTIONAL RADIOLOGY, 1989, 6 (01) : 8 - 9
  • [8] Benign prostatic hyperplasia
    Wilson, T
    [J]. BRITISH JOURNAL OF GENERAL PRACTICE, 1997, 47 (419): : 401 - 401
  • [9] Benign prostatic hyperplasia
    Nunes, Ricardo L. V.
    Antunes, Alberto A.
    Silvinato, Antonio
    Bernardo, Wanderley M.
    [J]. REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2018, 64 (10): : 876 - 881
  • [10] BENIGN PROSTATIC HYPERPLASIA
    MCCONNELL, JD
    [J]. JOURNAL OF UROLOGY, 1994, 152 (02): : 459 - 460